Cancer, Prostate
15
2
4
6
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
13.3%
2 terminated out of 15 trials
75.0%
-11.5% vs benchmark
13%
2 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (15)
Family History App in Personalized Medicine
Plant-based Diets and Risk of Cancer in the Adventist Health Study-2
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Evaluation of the Medical Service by Socio-aesthetics in Oncology
Prospective Validation of PSMA-RADS
Quest to Analyze One Thousand Humans Meditating
Diet Effect on Cancer Treatment Outcome
Patient Education Videos to Improve Patients' Experience During Radiotherapy Treatment: a National Project
Comorbidities And Reducing inEquitieS
Physical Activity Experiment on Male Prostate Cancer Patients
Volatile Anaesthesia and Perioperative Outcomes Related to Cancer Feasibility Study
Assessment of Sarcopenia at Diagnosis for Patients With Previously Untreated Metastatic Cancer or Hematologic Malignancy
Assessment of a New Fluorescence Imaging Technique Using Biopsies From Prostate Resection
Study to Assess Efficacy and Safety of Zoledronic Acid and the Value of Markers of Bone Resorption in the Prediction of Bone Metastases and Cancer Treatment-induced Bone Loss (CTIBL) in Patients With Prostate Cancer on Hormone Therapy
A Safety and Efficacy Study of Siltuximab (CNTO 328) in Male Subjects With Metastatic Hormone-Refractory Prostate Cancer (HRPC)